This document is an excerpt from the EUR-Lex website
Document 62021TN0601
Case T-601/21: Action brought on 20 September 2021 — Pharmadom v EUIPO — Wellstat Therapeutics (WELLMONDE)
Case T-601/21: Action brought on 20 September 2021 — Pharmadom v EUIPO — Wellstat Therapeutics (WELLMONDE)
Case T-601/21: Action brought on 20 September 2021 — Pharmadom v EUIPO — Wellstat Therapeutics (WELLMONDE)
IO C 481, 29.11.2021, p. 33–34
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
29.11.2021 |
EN |
Official Journal of the European Union |
C 481/33 |
Action brought on 20 September 2021 — Pharmadom v EUIPO — Wellstat Therapeutics (WELLMONDE)
(Case T-601/21)
(2021/C 481/47)
Language of the case: English
Parties
Applicant: Pharmadom (Boulogne-Billancourt, France) (represented by: M.-P. Dauquaire, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Wellstat Therapeutics Corp. (Rockville, Maryland, United States)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Other party to the proceedings before the Board of Appeal
Trade mark at issue: Application for European Union word mark WELLMONDE — Application for registration No 16 152 803
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 23 June 2021 in Case R 1776/2020-5
Form of order sought
The applicant claims that the Court should:
— |
annul the contested decision; |
Plea in law
— |
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |